ANI Pharmaceuticals, Inc. (ANIP) vs Kestra Medical Technologies, Ltd. (KMTS)

A side-by-side comparison of ANI Pharmaceuticals, Inc. and Kestra Medical Technologies, Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIP vs KMTS

growth of $100 · dividends reinvested · last 2y
ANIP +21.6% (+10.3%/yr)KMTS +29.8% (+13.9%/yr)KMTS compounded faster over this window
6080100120140160Start $1002026$122$130
ANIP KMTS

ANIP vs KMTS: by the numbers

  • •ANIP is the larger company ($1.62B vs $1.60B market cap).
  • •ANIP is profitable (10.82% net margin) while KMTS runs a net loss (-140.43%).

Metrics side by side

Valuation

MetricANIPKMTS
P/E ratio15.38N/A
Forward P/E7.68N/A
P/S ratio1.6615.03
P/B ratio2.717.21
EV / EBITDA6.74N/A

Profitability

MetricANIPKMTS
Gross margin51.01%53.89%
Operating margin15.35%-134.48%
Net margin10.82%-140.43%
ROE17.72%-67.40%
ROIC9.26%-47.99%

Growth (annualized)

MetricANIPKMTS
Revenue CAGR (5Y)35.61%N/A
Total return CAGR (5Y)16.86%N/A

Frequently asked

Is ANIP or KMTS more profitable?
ANIP runs the higher net margin — ANIP at 10.82% versus KMTS at -140.43%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.